Creabilis Overview
- Year Founded
-
2003
- Status
-
Acquired/Merged
- Employees
-
9
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$150M
Creabilis General Information
Description
Developer of pharmaceuticals for treatment of dermatological and inflammatory diseases. The company's lead product, CT327, is a topical treatment for chronic pruritus. It intents to build a pruritus franchise around the CT327 and CT340 candidates which were developed using the company's proprietary Low Systemic Exposure (LSE) platform technology.
Contact Information
Website
www.creabilis-sa.comCorporate Office
- 6 Denne Hill Business Centre
- Womenswold
- Canterbury CT4 6HD
- England, United Kingdom
Corporate Office
- 6 Denne Hill Business Centre
- Womenswold
- Canterbury CT4 6HD
- England, United Kingdom
Creabilis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 06-Dec-2016 | $150M | Completed | Generating Revenue | ||
| 5. Debt - General | 01-Sep-2015 | Completed | Generating Revenue | |||
| 4. Debt - General | 01-Jul-2014 | Completed | Generating Revenue | |||
| 3. Grant | 05-Nov-2012 | Completed | Startup | |||
| 2. Later Stage VC (Series B) | 04-Oct-2011 | $20M | $51.2M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 05-Jun-2008 | $31.2M | $31.2M | Completed | Startup |
Creabilis Comparisons
Industry
Financing
Details
Creabilis Competitors (13)
One of Creabilis’s 13 competitors is Aclaris Therapeutics, a Formerly VC-backed company based in Wayne, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Aclaris Therapeutics | Formerly VC-backed | Wayne, PA | ||||
| Bristol-Myers Squibb | Corporation | Princeton, NJ | ||||
| Biocon Biologics | Formerly PE-Backed | Bengaluru, India | ||||
| Samsung Bioepis | Corporate Backed or Acquired | Incheon, South Korea | ||||
| Gilead | Formerly VC-backed | Foster City, CA |
Creabilis Patents
Creabilis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2014177510-A2 | Polymer conjugates of indolocarbazole compounds in the treatment of pruritus | Inactive | 03-May-2013 | ||
| WO-2014177510-A3 | Polymer conjugates of indolocarbazole compounds in the treatment of pruritus | Inactive | 03-May-2013 | ||
| WO-2011003870-A2 | Mini-pegylated corticosteroids, compositions including same, and methods of making and using same | Inactive | 06-Jul-2009 | ||
| WO-2011003870-A3 | Mini-pegylated corticosteroids, compositions including same, and methods of making and using same | Inactive | 06-Jul-2009 | ||
| AU-2009331490-A1 | Synthesis of polymer conjugates of indolocarbazole compounds | Active | 22-Dec-2008 | A61K47/60 |
Creabilis Signals
Creabilis Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AbbVie Ventures | Corporate Venture Capital | Minority | ||
| Kreos Capital | Lender/Debt Provider | Minority | ||
| NeoMed Management | Venture Capital | Minority | ||
| Sofinnova Partners | Venture Capital | Minority |
Creabilis Investments (2)
Creabilis’s most recent deal was a Later Stage VC with Nautilus Biotech for . The deal was made on 30-Apr-2007.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Nautilus Biotech | 30-Apr-2007 | Later Stage VC | Biotechnology | ||
| Nautilus Biotech | 01-Mar-2005 | Later Stage VC | Biotechnology |
Creabilis FAQs
-
When was Creabilis founded?
Creabilis was founded in 2003.
-
Where is Creabilis headquartered?
Creabilis is headquartered in Canterbury, United Kingdom.
-
What is the size of Creabilis?
Creabilis has 9 total employees.
-
What industry is Creabilis in?
Creabilis’s primary industry is Drug Discovery.
-
Is Creabilis a private or public company?
Creabilis is a Private company.
-
What is the current valuation of Creabilis?
The current valuation of Creabilis is .
-
What is Creabilis’s current revenue?
The current revenue for Creabilis is .
-
How much funding has Creabilis raised over time?
Creabilis has raised $51.2M.
-
Who are Creabilis’s investors?
AbbVie Ventures, Kreos Capital, NeoMed Management, and Sofinnova Partners have invested in Creabilis.
-
Who are Creabilis’s competitors?
Aclaris Therapeutics, Bristol-Myers Squibb, Biocon Biologics, Samsung Bioepis, and Gilead are some of the 13 competitors of Creabilis.
-
When was Creabilis acquired?
Creabilis was acquired on 06-Dec-2016.
-
Who acquired Creabilis?
Creabilis was acquired by Sienna Biopharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process